| Literature DB >> 35657150 |
Penghui Liang1, Qi Guo2, Tianyu Zhao1, Cong-Ying Wen1, Zhangyu Tian1, Yanxue Shang1, Jinyan Xing2, Yongzhong Jiang3, Jingbin Zeng1.
Abstract
Immunoglobulin detection is essential for diagnosing progression of SARS-CoV-2 infection, for which SARS-CoV-2 IgG is one of the most important indexes. In this paper, Ag nanoparticles with ultrathin Au shells (∼2 nm) embedded with 4-mercaptobenzoic acid (MBA) (AgMBA@Au) were manufactured via a ligand-assisted epitaxial growth method and integrated into lateral flow immunoassay (LFIA) for colorimetric and SERS dual-mode detection of SARS-CoV-2 IgG. AgMBA@Au possessed not only the surface chemistry advantages of Au but also the superior optical characteristics of Ag. Moreover, the nanogap between the Ag core and the Au shell also greatly enhanced the Raman signal. After being modified with anti-human antibodies, AgMBA@Au recognized and combined with SARS-CoV-2 IgG, which was captured by the SARS-CoV-2 spike protein on the T line. Qualitative analysis was achieved by visually observing the color of the T line, and quantitative analysis was conducted by measuring the SERS signal with a sensitivity four orders of magnitude higher (detection limit: 0.22 pg/mL). The intra-assay and inter-assay variation coefficients were 7.7 and 10.3%, respectively, and other proteins at concentrations of 10 to 20 times higher than those of SARS-CoV-2 IgG could hardly produce distinguishable signals, confirming good reproducibility and specificity. Finally, this method was used to detect 107 clinical serum samples. The results agreed well with those obtained from enzyme-linked immunosorbent assay kits and were significantly better than those of the colloidal gold test strips. Therefore, this dual-mode LFIA has great potential in clinical practical applications and can be used to screen and trace the early immune response of SARS-CoV-2.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35657150 PMCID: PMC9211040 DOI: 10.1021/acs.analchem.2c01286
Source DB: PubMed Journal: Anal Chem ISSN: 0003-2700 Impact factor: 8.008
Figure 1(a) Flow chart of synthesis and functionalization of AgMBA@Au NPs. (b) Schematic diagram of the test strip structure and detection principle. (c) Interpretation of the detection results.
Figure 2Characterization of AgMBA@Au NPs. (a,b) TEM images of Ag and AgMBA@Au NPs. (c) HR-TEM images of a single AgMBA@Au NP. (d–f) EDX element mappings of Ag, Au, and their overlay. (g) EDX line scan image of AgMBA@Au NPs, and the inset shows the line scan area image. (h) UV–vis spectra of Ag and AgMBA@Au before and after etching, and the inset shows the photographs of AgMBA@Au NPs before and after etching.
Figure 3(a) Photographs of test strips obtained from PBS and serum samples with different concentrations of SARS-CoV-2 IgG (the asterisk represents the detection limit with naked eyes). (b) Linear response for SARS-CoV-2 IgG detection at the concentration from 10–9 to 10–4 mg/mL in PBS and serum. Error bars were calculated from three experiments. (c,d) Raman spectra obtained from (c) PBS and (d) serum samples with different concentrations of SARS-CoV-2 IgG.
Figure 4(a) Histogram of Raman signal intensities obtained from serum samples spiked with different proteins and the blank samples with the dual-mode LFIA method. (b) Histogram of Raman signal intensities obtained from SARS-CoV-2 IgG samples with the dual-mode LFIA method using AgMBA@Au stored at different times. Error bars were calculated from three experiments.
Reproducibility Test of the Dual-Mode Test Strips in PBS Solution
| intra-assay | inter-assay | |||||
|---|---|---|---|---|---|---|
| IgG concentration (mg/mL) | mean | SD | CV (%) | mean | SD | CV (%) |
| 10–4 | 6484 | 471 | 7.3 | 6493 | 759 | 11.6 |
| 10–5 | 5261 | 389 | 7.4 | 5487 | 570 | 10.4 |
| 10–6 | 4294 | 361 | 8.4 | 4151 | 407 | 9.8 |
| intra-assay variability 7.7% | inter-assay variability 10.6% | |||||
Reproducibility Test of the Dual-Mode Test Strips in Serum
| intra-assay | inter-assay | |||||
|---|---|---|---|---|---|---|
| IgG concentration (mg/mL) | mean | SD | CV (%) | mean | SD | CV (%) |
| 10–4 | 5734 | 590 | 10.3 | 5433 | 723 | 13.3 |
| 10–5 | 4549 | 365 | 8.0 | 4378 | 601 | 13.9 |
| 10–6 | 3576 | 321 | 9.0 | 3789 | 472 | 12.5 |
| intra-assay variability 9.1% | inter-assay variability 13.2% | |||||
Figure 5(a) Results of the dual-mode test strips used in actual sample testing. (b) Comparison of the dual-mode test strips with commercially available ELISA kits and colloidal gold test strips.